Application of AF-2364 in preparation of medicine for treating periprosthetic osteolysis
A technology of AF-2364, 1. AF-2364, applied in the field of new drug application, can solve the problems of insignificant therapeutic effect, no research, unsatisfactory therapeutic effect, etc., and achieve the effect of reducing degree, reducing osteolysis, and promoting expression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0032] The present invention will be further described below in conjunction with specific examples, but the examples are only exemplary and do not constitute any limitation to the scope of the present invention. Those skilled in the art should understand that the details and forms of the technical solutions of the present invention can be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the protection scope of the present invention.
[0033] 1. Materials and methods
[0034] 1. Materials
[0035] 1.1 Reagents and experimental equipment
[0036] 1.1.1 Main Drugs and Reagents
[0037] AF-2364 (Adjudin), purchased from MCE, the U.S.; Ethylenediaminetetraacetic acid (EDTA), purchased from Sigma, the U.S.; Calcein (Calcein), purchased from Sigma, the U.S.; Paraformaldehyde; PBS; DAB chromogen ; hematoxylin; eosin; absolute ethanol; distilled water; 10% chloral hydrate; titanium parti...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| height | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


